Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone MD-Lotion Extension Study in Hypogonadal Men
NCT00857454Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of testosterone topical solution in Hypogonadism, sponsored by Eli Lilly and Company. Primary endpoint: Draize Score at Day 190. Started Oct 2008; status: completed.
02
Drugs
testosterone topical solution
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00857454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857454.